Mark Hadden

591 citations
14 papers · 380 · h-index 11

Impact in

    • Asymmetric Synthesis and Catalysis
    • Chemical synthesis and alkaloids
    • Synthetic Organic Chemistry Methods
    • Multicomponent Synthesis of Heterocycles
    • Catalytic C–H Functionalization Methods
    • Synthesis and Biological Evaluation
    • Synthesis and Catalytic Reactions

Papers in

    • Asymmetric Synthesis and Catalysis 5
    • Synthesis and Characterization of Pyrroles 3
    • Advanced Synthetic Organic Chemistry 2
    • Organic Chemistry Cycloaddition Reactions 1
    • Receptor Mechanisms and Signaling 4

Mark Hadden

14 papers receiving 370 citations

Peers

Mark Hadden
Comparison fields: 5 of 46
  • Organic Chemistry 271
  • Endocrine and Autonomic Systems 15
  • Pharmacology 36
  • Molecular Biology 128
  • Cancer Research 28
Replace Jeffrey T. Mullaney with:
Jeffrey T. Mullaney United States
Odile E. Levy United States
Herman J. Crowley United States
Lin Chu United States
Rashmi Talwar India
Szymon Kłossowski Poland
Jiong Lan China
Jon G.A. Steadman United Kingdom
Timur Güngör France
Barry Teobald United Kingdom
Mark Hadden relative to Jeffrey T. Mullaney United States Jeffrey T. Mullaney's profile →
Citations per field
00.5×2.6×
Jeffrey T. Mullaney · 1×
Citations per year

Countries citing papers authored by Mark Hadden

Since Specialization
Citations

This map shows the geographic impact of Mark Hadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hadden more than expected).

Fields of papers citing papers by Mark Hadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hadden. The network helps show where Mark Hadden may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Hadden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Hadden Line = papers co-authored together Mark Hadden links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 199984
2 200652
3 200152
4 200236
5 200135
6 200930
7 200827
8 201014
9 201012
10 201011
11 201010
12 19987
13 19977
14 19983

About Mark Hadden

Mark Hadden is a scholar working on Organic Chemistry, Molecular Biology, Cancer Research, Pharmacology and Cellular and Molecular Neuroscience, having authored 14 papers that have together received 380 indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (4 papers), Synthesis and Characterization of Pyrroles (3 papers), Biochemical Analysis and Sensing Techniques (2 papers), Synthesis and Biological Activity (2 papers), Neuropeptides and Animal Physiology (2 papers), Advanced Synthetic Organic Chemistry (2 papers) and Organic Chemistry Cycloaddition Reactions (1 paper). The work is most often cited by research in Organic Chemistry (271 citations), Endocrine and Autonomic Systems (15 citations), Pharmacology (36 citations), Molecular Biology (128 citations) and Cancer Research (28 citations). Mark Hadden has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Paul J. Stevenson, M. Nieuwenhuyzen, Norris Thompson, Alan J. Henderson, Angus J.M. Cameron, Alan G. Jardine, Dianne Hillyard, Hilary Marshall, Nicola Johnston and Peter R. Guzzo. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron, Tetrahedron Letters, Journal of the Chemical Society Perkin Transactions 1 and Clinical and Experimental Pharmacology and Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact